Global Kidney Function Tests Market Size (2024 - 2029)

The kidney function tests market is anticipated to experience growth driven by factors such as the increasing prevalence of chronic kidney disease, diabetes, and hypertension, which contribute to kidney disorders. The market's expansion is further supported by heightened awareness of diagnostic methods and technological advancements in diagnostic tools. Despite these positive trends, challenges such as the high cost of diagnostic procedures and stringent regulations may impede the market's growth. The impact of the COVID-19 pandemic on kidney function has also influenced market dynamics, highlighting the importance of these tests in managing related health issues.

Market Size of Global Kidney Function Tests Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
Kidney Function Tests Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 5.62 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Kidney Function Tests Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Kidney Function Tests Market Analysis

The Kidney Function Tests Market is expected to register a CAGR of 5.62% during the forecast period, 2022-2027.

The pandemic has significantly impacted the kidney function tests market, as COVID-19 affected the patients' kidney function with the disease progression. According to a study titled "Association of Proteinuria and Hematuria with Acute Kidney Injury and Mortality in Hospitalized Patients with COVID-19" published in November 2020, more than 40% of admitted patients with COVID-19 showed symptoms of abnormal kidney function, such as albuminuria or hematuria. Furthermore, according to a study titled "Clinical Characteristics of COVID-19 Infection in Newborns and Pediatrics: A Systematic Review" published in April 2020, in adult patients, COVID-19 urinary incontinence was commonly found in patients with moderate to severe conditions. In children, exposure to COVID-19 has been reported among those who suffer from a mild form of COVID-19. From the onset of the disease, urinary tract infections were identified from day 1 to day 52. Thus, such instances notably impacted the growth rate of the market over the pandemic phase.

Furthermore, some of the factors driving the growth of the market include an increase in chronic kidney disease; the growing prevalence of underlying conditions such as diabetes and hypertension leading to kidney disorders; an increase in awareness about diagnostic methods for kidney function; and technological advances in diagnostic equipment and tools.

Diabetes and high blood pressure are considered major factors responsible for the growing burden of chronic kidney disease worldwide. Growing cases of diabetes will ultimately impact the growth of the market over the forecast period. For instance, according to the International Diabetes Atlas tenth edition in 2021, 537 million adults (20-79 years) were living with diabetes, approximately 1 in 10 individuals. This number is predicted to rise to 643 million by 2030 and 783 million by 2045.

Additionally, market players embrace a variety of strategies such as product launches, product developments, collaborations, acquisitions, integrations, and expansion to maximize their geographical reach worldwide. For example, in August 2020, RenalytixAI received approval from the United States Food and Drug Administration (FDA) for its new KidneyIntelX test. AI-enabled clinical trials are designed to identify and improve the clinical management of patients with type 2 diabetes and rapidly progressive kidney disease. The emergence of technologically advanced products is expected to further boost the market's growth over the forecast period.

Thus, the aforesaid factors are likely to have a positive impact on the market's growth. However, the high cost of diagnostic procedures and strict regulations are expected to hamper the kidney function tests market's growth in the near future.

Kidney Function Tests Industry Segmentation

As per the scope of the report, kidney function tests are simple procedures that generally use either blood or urine to help identify issues in the kidneys. The kidney function tests market is segmented by Product Type (Dipsticks, Disposables, and Reagents), Test Type (Urine Test (Urine Protein Tests, Creatinine Clearance Tests, and Microalbumin Tests), and Blood Tests (Serum Creatinine Tests, Glomerular Filtration Rate Tests, and Blood Urea Nitrogen Tests), End User (Hospitals and Clinics, Diagnostic Laboratories, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.

By Product Type
Dipsticks
Disposables
Reagents
By Test Type
Urine Tests
Urine Protein Tests
Creatinine Clearance Tests
Microalbumin Tests
Blood Tests
Serum Creatinine Tests
Glomerular Filtration Rate Tests
Blood Urea Nitrogen Tests
By End User
Hospitals and Clinics
Diagnostic Laboratories
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global Kidney Function Tests Market Size Summary

The Kidney Function Test Market is poised for significant growth, driven by an increasing prevalence of chronic kidney diseases and underlying conditions such as diabetes and hypertension. The market has been notably influenced by the COVID-19 pandemic, which highlighted the impact of the virus on kidney function, thereby accelerating the demand for diagnostic tests. Technological advancements in diagnostic equipment and a growing awareness of kidney health are further propelling market expansion. The introduction of innovative products, such as AI-enabled tests and smartphone-powered home tests, is expected to enhance diagnostic capabilities and accessibility, contributing to market growth.

In North America, the market is bolstered by a robust healthcare infrastructure and a high incidence of urinary tract infections, alongside the need for post-transplantation kidney function assessments. The region's response to the COVID-19 pandemic, including the development of new diagnostic assays, has also played a crucial role in market dynamics. Despite challenges such as high diagnostic costs and regulatory hurdles, the market remains competitive, with major players like F.Hoffmann-La Roche Ltd., ACON Laboratories Inc., and Quest Diagnostics leading the charge. These companies are actively engaging in strategic initiatives, including product launches and collaborations, to expand their market presence and drive innovation in kidney function testing.

Explore More

Global Kidney Function Tests Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Chronic Kidney Diseases

      2. 1.2.2 Increasing Awareness about the Diagnostic Methods for the Proper Functioning of the Kidney

      3. 1.2.3 Technological Advancements in Diagnostic Machinery and Tools

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Diagnostic Procedures

      2. 1.3.2 Stringent Regulations Norms

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product Type

      1. 2.1.1 Dipsticks

      2. 2.1.2 Disposables

      3. 2.1.3 Reagents

    2. 2.2 By Test Type

      1. 2.2.1 Urine Tests

        1. 2.2.1.1 Urine Protein Tests

        2. 2.2.1.2 Creatinine Clearance Tests

        3. 2.2.1.3 Microalbumin Tests

      2. 2.2.2 Blood Tests

        1. 2.2.2.1 Serum Creatinine Tests

        2. 2.2.2.2 Glomerular Filtration Rate Tests

        3. 2.2.2.3 Blood Urea Nitrogen Tests

    3. 2.3 By End User

      1. 2.3.1 Hospitals and Clinics

      2. 2.3.2 Diagnostic Laboratories

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global Kidney Function Tests Market Size FAQs

The Global Kidney Function Tests Market is projected to register a CAGR of 5.62% during the forecast period (2024-2029)

F.Hoffmann-La Roche Ltd, Nova Biomedical, Quest Diagnostics , 77 Elektronika Kft and ACON Laboratories, Inc. are the major companies operating in the Global Kidney Function Tests Market.

Kidney Function Test Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)